Evaluation of Anti-Inflammatory Treatment in Dry Eye Patients
NCT01276223
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
722
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye Disease
Interventions
DRUG:
Difluprednate 0.05% ophthalmic emulsion
OTHER:
Difluprednate vehicle
Sponsor
Alcon Research